Jeffrey Alan Wolf - 29 Apr 2025 Form 4 Insider Report for Theriva Biologics, Inc. (TOVX)

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	TOVX	Stock Options (right to buy)	Award	$0	+25,000		$0.000000	25,000	29 Apr 2025	Common Stock	25,000	$1.41	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Id	Content
F1	These stock options vest pro rata on a monthly basis over 12 months.